# Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen

> **NCT00518518** · PHASE4 · COMPLETED · sponsor: **Medical University of Lodz** · enrollment: 50 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Staloral 300
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00518518
- **Lead sponsor:** Medical University of Lodz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2009-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518518, "Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00518518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*